TRIB3抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P08909(TRIB3 Antibody) at dilution 1/40. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P08909(TRIB3 Antibody) at dilution 1/40. (Original magnification: ×200)    

  
  

**Background of TRIB3 Antibody**

TRIB3 (Tribbles homolog 3) is a pseudokinase belonging to the Tribbles family of proteins, which regulate cellular processes such as stress response, metabolism, apoptosis, and cancer progression. Unlike typical kinases, TRIB3 lacks catalytic activity but acts as a scaffold or modulator in signaling pathways. It interacts with key molecules like ATF4. CHOP, and AKT, influencing pathways such as the unfolded protein response (UPR), insulin signaling, and cell survival. TRIB3 is implicated in diseases including cancer, diabetes, and neurodegenerative disorders, where its expression often correlates with disease progression or therapeutic resistance.

TRIB3 antibodies are essential tools for detecting and quantifying TRIB3 protein levels in research. They enable the study of TRIB3's role in cellular stress, metabolic dysregulation, and tumorigenesis through techniques like Western blotting, immunohistochemistry, and immunofluorescence. Due to TRIB3's context-dependent roles (e.g., acting as a tumor suppressor or promoter), reliable antibodies are critical for accurate experimental outcomes. Most TRIB3 antibodies are generated using immunogenic peptides or recombinant protein fragments, and their specificity is validated via knockout controls or siRNA-mediated silencing. Researchers utilize these antibodies to explore TRIB3's involvement in disease mechanisms, therapeutic targeting, and biomarker discovery, underscoring its growing relevance in translational medicine.